Market closed
Clearmind Medicine Inc./$CMND
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Ticker
$CMND
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Vancouver, Canada
Employees
-
Website
CMND Metrics
BasicAdvanced
$5.3M
-
-$1.29
-1.46
-
Price and volume
Market cap
$5.3M
Beta
-1.46
52-week high
$1.30
52-week low
$1.00
Financial strength
Current ratio
1.722
Quick ratio
1.645
Long term debt to equity
0.242
Total debt to equity
1.612
Interest coverage (TTM)
-139.62%
Management effectiveness
Return on assets (TTM)
-43.89%
Return on equity (TTM)
-125.61%
Valuation
Price to book
1.69
Price to tangible book (TTM)
1.76
Price to free cash flow (TTM)
-0.849
Growth
Earnings per share change (TTM)
-91.02%
3-year earnings per share growth (CAGR)
-77.25%
CMND News
AllArticlesVideos
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
GlobeNewsWire·5 days ago
Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones
GlobeNewsWire·2 weeks ago
Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Clearmind Medicine Inc. stock?
Clearmind Medicine Inc. (CMND) has a market cap of $5.3M as of April 06, 2025.
What is the P/E ratio for Clearmind Medicine Inc. stock?
The price to earnings (P/E) ratio for Clearmind Medicine Inc. (CMND) stock is 0 as of April 06, 2025.
Does Clearmind Medicine Inc. stock pay dividends?
No, Clearmind Medicine Inc. (CMND) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Clearmind Medicine Inc. dividend payment date?
Clearmind Medicine Inc. (CMND) stock does not pay dividends to its shareholders.
What is the beta indicator for Clearmind Medicine Inc.?
Clearmind Medicine Inc. (CMND) has a beta rating of -1.46. This means that it has an inverse relation to market volatility.
